BBV152/BBV154 Heterologus Prime-Boost Study

Clinical trial NCT05639998 · COMPLETED

Trial details

NCT number: NCT05639998
Sponsor: Bharat Biotech International Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection

Start date: 2021-09-01
Primary completion: 2022-03-01
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.